logo-loader

Cynata Therapeutics to raise capital

Published: 23:00 18 Jan 2017 GMT

AustralianCash757x468_587ff9116abe8
Cynata has been granted a trading halt

Cynata is an Australian stem cell and regenerative medicine company.

The halt will remain in place until the opening of trade on Monday 23rd January 2017, or earlier if an announcement is made to the market.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

5 minutes ago